Dermatomyositis-like illness following kava-kava ingestion

Journal of Clinical Rheumatology

Volumn 5, Issue 6, 1999, Pages 342-345

  Guro Razuman, Samerah ^a   Anand, Prachi ^a   Hu, Qinglong ^a   Mir, Rabia ^a  

^a NASSAU UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Alternative medicine; Dermatomyositis; Kava kava

Indexed keywords

CREATINE KINASE; KAVA; PREDNISONE;

ADULT; ANXIETY NEUROSIS; ARTICLE; CASE REPORT; CREATINE KINASE BLOOD LEVEL; DERMATOMYOSITIS; ELECTROMYOGRAM; FEMALE; HERBAL MEDICINE; HUMAN; MUSCLE BIOPSY; MUSCLE WEAKNESS; PRIORITY JOURNAL; RASH; SKIN BIOPSY;

EID: 0032803352     PISSN: 10761608     EISSN: None     Source Type: Journal    
DOI: 10.1097/00124743-199912000-00008     Document Type: Article

References (14)

1. Canedy D. Real medicine or medicine show? Growth of herbal sales raises issues about value. New York Times. July 23, 1998:C1.
2. O'Hara M, Kiefer D, Farrell K, Kemper K. A review of 12 commonly used medicinal herbs. Arch Fam Med 1998;7:523-36.
3. Murray M, Pizzomo J. Natural medicine. 2nd ed. Rocklin, California: Prima Publishing; 1995. p.255-9.
4. Norton SA, Ruze P. Kava dermopathy. J Am Acad Dermatol 1994;31:89-97.
5. Heiligenstein E, Guenther G. Over-the-counter psychotropics: a review of melatonin, St. John's Wort, valerian and kava-kava. College Health 1998;46:271-6.
6. Backhauss C, Krieglstein J. Extract of kava (Piper methysticum) and its methysticin constituents protect brain tissue against ischemic damage in rodents. Eur J Pharmacol 1992;215:265-9.
7. Seitz U, Schule A, Gleitz J. [3H]-monoamine uptake inhibition properties of kava pyrones. Planta Med 1997;63:548-9.
8. Anonymous. Kava. Harvard Women's Health Watch. Aug 1998:6.
9. Matthews JD, Riley MD, Fejo L, Munoz E, Milns NR, Gardner ID, et al. Effects of the heavy usage of kava on physical health: summary of a pilot survey in an aboriginal community. Med J Aust 1988;148:548-55.
10. Ruze P. Kava induced dermopathy: a niacin deficiency? Lancet 1990;335:1442-5.
11. Winkelmann RK, Perry HO, Achor RWP. Cutaneous syndromes produced as side effects of triparanol therapy. Arch Dermatol 1963;87:372-7.
12. Uta J, Ingolf F, Dirk R, Gollnick HPM. Sebotropic drug reaction resulting from kava-kava extract therapy: a new entity?. J Am Acad Dermatol 1998;38:104-6.
13. Gleitz J, Beile A, Wilkens P, Ameri A, Peters T. Antithrombotic action of the kava pyrone (+)-kavain prepared from Piper methysticum on human platelets. Planta Med 1997;63:27-30.
14. Engel AG, Fanzeni-Armstrong C. The polymyositis and dermatomyositis syndromes. In: Myology basic and clinical. New York, NY: McGraw-Hill, Inc; 1994. p.1335-83.